Simpson Thacher Adds Recognised Private Funds Lawyer in London
Simpson Thacher & Bartlett LLP announced today that James Board will join as a Partner in the Firm’s London office.
“We are delighted to welcome James to the Firm,” said Bill Dougherty, Chairman of Simpson Thacher’s Executive Committee. “We have a market-leading global Private Funds Practice and James’ skills and depth of experience will benefit our private fund sponsor clients in the United Kingdom, throughout Europe and around the world.”
James advises primarily on the establishment and operation of credit funds, including special situations, distressed, direct lending, liquid, structured and real estate credit funds. He also has substantial experience guiding sponsors in establishing single investor funds and managed accounts involving institutional investors. In addition, James advises on the structure and terms of incentive arrangements, including co-investment, executive carried interest and similar agreements. Named a rising star by Private Debt Investor and Euromoney LMG, he joins the Firm from Kirkland & Ellis LLP.
“James has established himself as a go-to advisor on complex fundraises, especially in the credit funds space, and he will be an excellent addition to our stellar London team,” said Jason Glover, Managing Partner of the London office and Head of the Firm’s London Funds Practice. “The addition of James marks the latest step in the continued growth of our private funds platform in Europe and follows the recent announcement concerning Owen Lysak joining the Firm to lead our European regulatory practice.”
“Recognised as a rising star in the private funds industry, James will further bolster the strength of our market-leading practice and enhance our ability to provide strategic advice across the spectrum of private funds asset classes and strategies,” said Michael Wolitzer, Head of Simpson Thacher’s Private Funds Practice.
Established in 2011, Simpson Thacher’s London Funds Practice advises many of Europe’s preeminent private fund sponsors on significant capital raisings and ongoing fund-related matters. The practice covers the full spectrum of private funds, including buyout, growth, venture capital, core private equity, credit, infrastructure, energy and real estate. In addition to providing U.S. and English law capability on fund formation matters, the global Private Funds Practice offers clients forward-thinking, innovative and practical solutions to complex regulatory, compliance and enforcement issues.
ABOUT SIMPSON THACHER
Simpson Thacher & Bartlett LLP (www.simpsonthacher.com) is one of the world’s leading international law firms. The Firm was established in 1884 and has more than 1,000 lawyers. Headquartered in New York with offices in Beijing, Hong Kong, Houston, London, Los Angeles, Palo Alto, São Paulo, Tokyo and Washington, D.C., the Firm provides coordinated legal advice and transactional capability to clients around the globe.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302006203/en/
Contact information
Caroline Fatchett
Associate Director, Communications
Simpson Thacher & Bartlett LLP
caroline.fatchett@stblaw.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 13:01:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
I-care Becomes a Unicorn23.12.2025 11:45:00 EET | Press release
I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil
Liquid Reply Joins the Agentic AI Foundation (AAIF) to Advance Open, Trusted Agentic AI23.12.2025 11:00:00 EET | Press release
Liquid Reply, specialising in platform engineering and cloud-native technologies within the Reply Group, today announced that it has joined the Agentic AI Foundation (AAIF). The newly established foundation was launched under the auspices of the Linux Foundation and provides a neutral, open governance framework for the development of agent-based AI systems. Members collaborate transparently to develop tools, protocols, and specifications that remain available as open-source resources for the global community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223604862/en/ Through its membership, Liquid Reply will engage the AAIF community and actively support the establishment of open standards for the next generation of AI-powered applications. By joining the AAIF, Liquid Reply reinforces its commitment to open-source and community-driven innovation, and supports the creation of shared technical foundations for the responsi
Rajant Kinetic Mesh® Proves Subterranean Connectivity During NATO ARRC “Ex AVENGER TRIAD 25” Exercise23.12.2025 11:00:00 EET | Press release
Rajant Corporation, the exclusive provider of peer to peer, private Kinetic Mesh® networks consisting of BreadCrumb® wireless nodes powered by InstaMesh® routing, today announced the successful completion of a subterranean communications trial during NATO Allied Rapid Reaction Corps’ (ARRC) primary exercise of the year, Ex AVENGER TRIAD 25, which was conducted in October–November 2025. During the exercise, Rajant provided the communications equipment that delivered robust underground bandwidth in a retired mine in England. The Rajant network operated as a transport-agnostic, multi-bearer networking overlay that unified disparate communication technologies into a single resilient transport fabric, integrating cleanly with existing network transports and mission systems. ARRC users and the British Army’s 22 Signal Regiment recognized the utility of the approach and identified avenues to exploit the capability further, most notably a wireless subterranean headquarters concept, while also
Spain’s CESGA Selects IQM and Telefónica to Deploy Advanced Quantum Computing Infrastructure23.12.2025 10:53:00 EET | Press release
IQM Quantum Computers, the global leader in deployed, on-premises computers, and Telefónica, a global telecommunications provider, have joined forces to sign a purchase agreement with the Galician Supercomputing Center (CESGA) to install two full-stack quantum computers in Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223742835/en/ Spain’s CESGA selects IQM and Telefónica to deploy advanced quantum computing infrastructure Under the agreement, IQM will deliver and install a 54-qubit IQM Radiance, designed for integration into high-performance computing centres, together with a 5-qubit IQM Spark system dedicated to education. The systems are scheduled for delivery by June 2026. The deployment will expand CESGA’s advanced computing capabilities and strengthen its role as a key national and European research infrastructure. The systems will be used by the scientific community and made accessible to leading companies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
